Epirubicin

ATP binding cassette subfamily C member 1 ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34848465 Differences in Transport Characteristics and Cytotoxicity of Epirubicin and Doxorubicin in HepG2 and A549 Cells. 2021 Dec 1
2 32196840 Tripartite motif protein 25 is associated with epirubicin resistance in hepatocellular carcinoma cells via regulating PTEN/AKT pathway. 2020 Jul 2
3 28968471 Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells. 2017 2
4 25677905 Effect of GSTP1 and ABCC4 gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-5-fluorouracil-based chemotherapy in Bangladeshi breast cancer patients. 2015 Jul 1
5 23396606 Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC). 2013 Jun 3
6 23867903 Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro. 2013 Oct 5 2
7 21903448 Nuclear translocation of MRP1 contributes to multidrug resistance of mucoepidermoid carcinoma. 2011 Dec 1
8 19622290 [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer]. 2009 Apr 2
9 16628497 Chromosome microdissection identifies genomic amplifications associated with drug resistance in a leukemia cell line: an approach to understanding drug resistance in cancer. 2006 1
10 12576456 RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. 2003 Feb 1
11 10428874 Localization of a substrate specificity domain in the multidrug resistance protein. 1999 Aug 6 2
12 9610729 Induction of broad drug resistance in small cell lung cancer cells and its reversal by paclitaxel. 1998 May 29 1
13 7752673 Drug resistance mechanisms and MRP expression in response to epirubicin treatment in a human leukaemia cell line. 1995 Apr 2